Disease heterogeneity: Matching biomarkers to diverse CNS disorder subtypes
05 May 2026
Biomarkers in Discovery
- What new and emerging biomarker modalities show the most promise for improving disease detection, prognosis, or treatment response?
- How can big data and multi-omics approaches be leveraged to better define disease subtypes and improve our understanding of disease heterogeneity?
- What strategies are most effective for operationalizing patient diagnosis and stratification in routine clinical practice, and what barriers still need to be addressed?
